PFM
Privium Fund Management Portfolio holdings
AUM
$480M
1-Year Est. Return
77.45%
This Fund
S&P 500
1 Year Est. Return
+77.45%
AUM
$480M
AUM Growth
-$62.8M
(-12%)
Holding
64
Top Buys
| 1 | +$10.4M | |
| 2 | +$5.38M | |
| 3 | +$5.07M | |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
+$4.16M |
| 5 |
Ionis Pharmaceuticals
IONS
|
+$3.88M |
Top Sells
| 1 | +$5.47M | |
| 2 | +$3.85M | |
| 3 | +$2.68M | |
| 4 |
Arrowhead Research
ARWR
|
+$1.98M |
| 5 |
VZLA
Vizsla Silver
VZLA
|
+$1.12M |
Sector Composition
| 1 | Healthcare | 33.85% |
| 2 | Consumer Discretionary | 24.98% |
| 3 | Technology | 24.21% |
| 4 | Financials | 8.49% |
| 5 | Communication Services | 6.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Tesla
TSLA
$1.66T
| $82.5M | 17.18% |
222,000
-6,500
|
|
||
2
Shopify
SHOP
$149B
| $48.3M | 10.05% |
407,000
-3,000
|
|
||
3
Spotify
SPOT
$106B
| $32.5M | 6.76% |
67,000
-1,000
|
|
||
4
Palantir
PLTR
$344B
| $29.3M | 6.09% |
200,000
|
|
||
5
Amazon
AMZN
$2.95T
| $26M | 5.42% |
125,000
+4,000
|
|
||
|
6
Arrowhead Research
ARWR
$11.1B
| $23M | 4.79% |
366,936
-31,268
|
|
||
|
7
Ionis Pharmaceuticals
IONS
$12.8B
| $21.8M | 4.53% |
290,024
+49,200
|
|
||
8
Lemonade
LMND
$4.46B
| $16M | 3.33% |
255,259
+7,000
|
|
||
9
NVIDIA
NVDA
$5.19T
| $14.1M | 2.94% |
81,000
|
|
||
10
Coinbase
COIN
$48B
| $13.8M | 2.87% |
79,000
|
|
||
11
Advanced Micro Devices
AMD
$845B
| $12.6M | 2.63% |
62,000
+2,000
|
|
||
12
AST SpaceMobile
ASTS
$39.8B
| $12M | 2.5% |
145,000
|
|
||
13
Sea Limited
SE
$56.3B
| $11.4M | 2.38% |
138,000
|
|
||
14
Iris Energy
IREN
$22.9B
| $11M | 2.28% |
320,150
+40,150
|
|
||
15
Axsome Therapeutics
AXSM
$12B
| $9.93M | 2.07% |
58,729
+1,851
|
|
||
16
Esperion Therapeutics
ESPR
$806M
| $9.04M | 1.88% |
+3,299,441
|
|
||
17
ProQR Therapeutics
PRQR
$165M
| $8.86M | 1.84% |
5,467,149
+109,387
|
|
||
18
Biogen
BIIB
$29B
| $8.03M | 1.67% |
43,800
-29,680
|
|
||
19
uniQure
QURE
$1.57B
| $7.95M | 1.66% |
486,520
+70,250
|
|
||
20
Ultragenyx Pharmaceutical
RARE
$2.29B
| $7.64M | 1.59% |
364,802
+7,300
|
|
||
21
Arcutis Biotherapeutics
ARQT
$2.68B
| $7.56M | 1.57% |
320,972
+15,000
|
|
||
22
BioMarin Pharmaceuticals
BMRN
$10.2B
| $5.21M | 1.09% |
+92,305
|
|
||
23
Vertex Pharmaceuticals
VRTX
$114B
| $5.07M | 1.06% |
11,355
+2,000
|
|
||
24
Denali Therapeutics
DNLI
$3.32B
| $4.89M | 1.02% |
+254,857
|
|
||
25
UroGen Pharma
URGN
$1.4B
| $4.28M | 0.89% |
238,122
+23,500
|
|